Delivery Order SPE2DB25D3022-SPE2DB25FWCHK
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,301.76 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 micrograms in 12-gram units. This award, issued on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a firm fixed-price delivery order with no set-aside designation. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution...
- The Defense Logistics Agency awarded a delivery order valued at $2,075.75 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers. This non-set-aside contract was awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, and operates under firm fixed price terms. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued under...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Fluticasone Propionate HFA 220 mcg inhalers in 12-gram quantities. This firm fixed-price delivery order, valued at $14,846.64 with an ultimate completion date of August 11, 2025, was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as...
- The Defense Logistics Agency awarded a $6,621.75 delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 micrograms in 12-gram units, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child action under AmerisourceBergen's larger pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $1,528.68 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 44 micrograms in 10.6-gram inhalers. This non-set-aside, competitively awarded delivery order was issued on August 12, 2025, with an ultimate completion date of August 13, 2025, and reflects a firm fixed price contract type. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform fulfillment at its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers, with a contract value of $24,494.88 and an ultimate completion date of July 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued as a competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Fluticasone Propionate HFA 220 micrograms in 12-gram units, with a contract ceiling value of $6,207.43. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion on August 20, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The award represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Fluticasone Propionate HFA 110 mcg in 12-gram units, valued at $1,789.77. This is a firm fixed-price delivery order with an ultimate completion date of July 22, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was competitively awarded. This delivery order represents a child...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,824.05 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 220 micrograms in a 12-gram inhaler, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation will be fulfilled from AmerisourceBergen's operations in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's broader Indefinite Delivery...
- The U.S. Defense Department's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,532.28 for Fluticasone Propionate HFA 110 MCG inhalers (12GM units), with an ultimate completion date of August 11, 2025. This contract was competitively awarded on August 8, 2025, under a firm fixed-price arrangement with no set-aside designation. The delivery order was placed to AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate...
- SPE2DB25D3022Indefinite Delivery Contract
- SPE2DB25D3022-SPE2DB25FWCHKDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 220 micrograms in a 12-gram formulation, valued at $1,552.27. This competitively awarded, firm fixed-price delivery order was issued on August 20, 2025, with an ultimate completion date of August 21, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. No set-aside designation was applied to this contract action. This delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military and veteran healthcare systems. The Fluticasone Propionate delivery fulfills ongoing pharmaceutical supply requirements within DLA's global medical supply chain, enabling the company to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 8/20/25 |